WNT3A and neoplasm: Among these tumor samples, 52 (23.4%) patients displayed high Wnt3a expression, 95 (42.8%) patients with middle Wnt3a expression and 75 (33.8%) patients with low Wnt3a expression (Fig. 1A-C; Table 1).